B2M and osteosarcoma: Next, we compared thetranscriptional stability of several normalizers that were formerly recommendedfor use in canine osteosarcoma without transcriptome-wide expression profiling forthis context such as OAZ1 [16] or B2M,HNRNPH, RPS5 and RPS19 [17](Table S5).